168 related articles for article (PubMed ID: 30826457)
1. Autophagy inhibition plays a protective role against 3, 4-methylenedioxymethamphetamine (MDMA)-induced loss of serotonin transporters and depressive-like behaviors in rats.
Shih JH; Chiu CH; Ma KH; Huang YS; Shiue CY; Yeh TY; Kao LT; Lin YY; Li IH
Pharmacol Res; 2019 Apr; 142():283-293. PubMed ID: 30826457
[TBL] [Abstract][Full Text] [Related]
2. Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity.
Li IH; Ma KH; Kao TJ; Lin YY; Weng SJ; Yen TY; Chen LC; Huang YS
Neurotoxicology; 2016 Jan; 52():114-26. PubMed ID: 26610922
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of brain SERT occupancy by resveratrol against MDMA-induced neurobiological and behavioral changes in rats: A 4-[¹⁸F]-ADAM/small-animal PET study.
Shih JH; Ma KH; Chen CF; Cheng CY; Pao LH; Weng SJ; Huang YS; Shiue CY; Yeh MK; Li IH
Eur Neuropsychopharmacol; 2016 Jan; 26(1):92-104. PubMed ID: 26612383
[TBL] [Abstract][Full Text] [Related]
4. Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET.
Li IH; Huang WS; Shiue CY; Huang YY; Liu RS; Chyueh SC; Hu SH; Liao MH; Shen LH; Liu JC; Ma KH
Neuroimage; 2010 Jan; 49(2):1259-70. PubMed ID: 19682588
[TBL] [Abstract][Full Text] [Related]
5. MDMA-induced neurotoxicity of serotonin neurons involves autophagy and rilmenidine is protective against its pathobiology.
Mercer LD; Higgins GC; Lau CL; Lawrence AJ; Beart PM
Neurochem Int; 2017 May; 105():80-90. PubMed ID: 28122248
[TBL] [Abstract][Full Text] [Related]
6. Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.
Lizarraga LE; Cholanians AB; Phan AV; Herndon JM; Lau SS; Monks TJ
Toxicol Sci; 2015 Jan; 143(1):209-19. PubMed ID: 25370842
[TBL] [Abstract][Full Text] [Related]
7. Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage.
Costa G; Morelli M; Simola N
Neurotox Res; 2017 Nov; 32(4):563-574. PubMed ID: 28597409
[TBL] [Abstract][Full Text] [Related]
8. Repeated intermittent MDMA binges reduce DAT density in mice and SERT density in rats in reward regions of the adolescent brain.
Kindlundh-Högberg AM; Schiöth HB; Svenningsson P
Neurotoxicology; 2007 Nov; 28(6):1158-69. PubMed ID: 17692920
[TBL] [Abstract][Full Text] [Related]
9. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.
Xie T; Tong L; McLane MW; Hatzidimitriou G; Yuan J; McCann U; Ricaurte G
Neuropsychopharmacology; 2006 Dec; 31(12):2639-51. PubMed ID: 16452989
[TBL] [Abstract][Full Text] [Related]
10. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
Biezonski DK; Meyer JS
J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
[TBL] [Abstract][Full Text] [Related]
11. Autophagy activation is involved in 3,4-methylenedioxymethamphetamine ('ecstasy')--induced neurotoxicity in cultured cortical neurons.
Li IH; Ma KH; Weng SJ; Huang SS; Liang CM; Huang YS
PLoS One; 2014; 9(12):e116565. PubMed ID: 25551657
[TBL] [Abstract][Full Text] [Related]
12. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
13. Dextromethorphan moderates reward deficiency associated with central serotonin transporter availability in 3,4-methylenedioxy-methamphetamine-treated animals.
Chiu CH; Ma KH; Huang EY; Chang HW; Weng SJ; Yu TH; Farn SS; Kuo YY; Huang WS; Cheng CY; Tao PL; Yeh SH
J Chin Med Assoc; 2024 May; 87(5):538-549. PubMed ID: 38587377
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.
McCann UD; Szabo Z; Vranesic M; Palermo M; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
Psychopharmacology (Berl); 2008 Oct; 200(3):439-50. PubMed ID: 18661256
[TBL] [Abstract][Full Text] [Related]
15. Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan.
Wang X; Baumann MH; Dersch CM; Rothman RB
Neuroscience; 2007 Aug; 148(1):212-20. PubMed ID: 17629409
[TBL] [Abstract][Full Text] [Related]
16. Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats.
Shen EY; Ali SF; Meyer JS
Neuropharmacology; 2011 Dec; 61(8):1183-92. PubMed ID: 21763331
[TBL] [Abstract][Full Text] [Related]
17. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
Callaghan PD; Owens WA; Javors MA; Sanchez TA; Jones DJ; Irvine RJ; Daws LC
J Neurochem; 2007 Feb; 100(3):617-27. PubMed ID: 17181558
[TBL] [Abstract][Full Text] [Related]
18. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
Kirilly E
Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
[TBL] [Abstract][Full Text] [Related]
19. Acute tryptophan depletion potentiates 3,4-methylenedioxymethamphetamine-induced cerebrovascular hyperperfusion in adult male Wistar rats.
van Donkelaar EL; Kelly PA; Dawson N; Blokland A; Prickaerts J; Steinbusch HW; Ferrington L
J Neurosci Res; 2010 May; 88(7):1557-68. PubMed ID: 19998482
[TBL] [Abstract][Full Text] [Related]
20. (+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane.
Wang X; Baumann MH; Xu H; Morales M; Rothman RB
J Pharmacol Exp Ther; 2005 Sep; 314(3):1002-12. PubMed ID: 15937150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
